TL;DR — The 30-Second Summary
Jardiance (empagliflozin) is licensed in the UK for type 2 diabetes, heart failure, and chronic kidney disease — not for weight loss. It causes modest weight loss (2-3kg over six months) as a side effect of excreting glucose in urine. The NHS won’t prescribe it for weight loss alone. For significant, evidence-based weight management, GLP-1 medications like Wegovy or Mounjaro are the proven options, now available on the NHS for eligible patients.
If you’ve seen online discussions about Jardiance and weight loss, you’re not alone. The search for effective weight management tools is understandable, and it’s natural to wonder about any medication that might help. When it comes to Jardiance specifically, though, it’s crucial to separate hopeful speculation from medical reality in the UK. This guide gives you an honest look at what Jardiance actually is, the real evidence for weight loss, why it’s not a weight loss drug, and what your safer evidence-based options are within the NHS pathway. No marketing — just the medical facts.
What Jardiance actually is
Jardiance is the brand name for the drug empagliflozin, manufactured by Boehringer Ingelheim. It belongs to a class of medications called SGLT2 inhibitors — sodium-glucose cotransporter-2 inhibitors. The name describes exactly how the drug works: it blocks a specific protein in the kidneys.
MHRA-licensed indications (and what’s NOT on the list)
In the UK, Jardiance is approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and used within the NHS for three specific licensed indications. First approved in 2014 for diabetes, its role has expanded based on robust trial evidence showing benefits for the heart and kidneys, independent of glucose-lowering effects. NICE recommends it on the NHS for these conditions if you meet clinical criteria. Importantly: weight loss is not on this list.
- Type 2 diabetes — for blood glucose control
- Heart failure — both with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF)
- Chronic kidney disease (CKD) — to slow progression in eligible patients. Weight loss is NOT licensed.
How it actually works (mechanism)
Understanding how Jardiance works explains both its benefits and its side effects.
Glucose-in-urine = the calorie loss explanation
- SGLT2 protein normally reabsorbs glucose in kidneys
- Jardiance blocks SGLT2 → glucose excreted in urine
- ~70-90g/day glucose excretion = ~280-360 calories lost daily
- First 1-2 weeks: extra “weight loss” is mostly fluid (diuretic effect)
Independent of insulin pathway — doesn’t directly cause hypoglycaemia when used alone.
The weight loss evidence (honest review)
The weight loss seen with Jardiance is real, but it’s consistently modest and is a side effect, not a primary treatment goal.
| Trial / source | Population | Weight loss result | Quality |
|---|---|---|---|
| EMPA-REG OUTCOME (2015 NEJM) | T2D + cardiovascular risk | Sustained 2-3kg over 6+ months | Landmark RCT — high quality |
| EMPEROR-Reduced/Preserved | Heart failure ± diabetes | Modest weight reduction secondary outcome | High quality |
| 2023 SGLT2 meta-analyses | Multiple T2D studies | Mean 2.5kg across drug class | Good — class effect |
| Non-diabetic populations | Small studies | Minor effect <2kg | Limited data |
Effect plateaus 6-12 months. Most studies coupled with diet/exercise — hard to isolate drug-only contribution.
Why it’s NOT a weight loss drug (UK regulatory reality)
The MHRA hasn’t licensed Jardiance for weight management. NICE doesn’t recommend SGLT2 inhibitors for treating obesity. The NHS won’t prescribe Jardiance for weight loss alone — period.
Some private clinics offer “off-label” Jardiance prescriptions for weight loss. This is technically legal but medically contentious. Off-label prescribing without strong evidence raises ethical and safety questions, particularly: limited data in non-diabetic populations; real risk of UTIs, fungal infections, dehydration with no balancing benefit; no NHS oversight or aftercare; and costs £40-£100/month privately, often without proper monitoring.
Side effects + who should not take it
Like all medicines, Jardiance has real side effects. Some are common; some are rare but serious.
Common + serious side effects to know
- Common: UTIs, genital fungal infections (thrush), increased urination + thirst
- Common: mild dehydration + dizziness
- RARE serious: euglycaemic DKA (medical emergency — A&E)
- RARE serious: Fournier’s gangrene (urgent surgical)
- Hypoglycaemia risk only with insulin/sulphonylurea combos
- AVOID: type 1 diabetes, severe kidney disease (eGFR <20), pregnancy/breastfeeding, history of DKA
Hydrate well — particularly during illness. Disclose full medical history when starting Jardiance.
What ACTUALLY causes weight loss in the UK (evidence-based)
For significant, evidence-based weight loss, the NHS offers genuinely effective pathways.
| Treatment | Average weight loss | NHS criteria | Mechanism |
|---|---|---|---|
| Mounjaro tirzepatide | 15-22% body weight | BMI 30+ or 27+ with comorbidity | GLP-1+GIP agonist |
| Wegovy semaglutide | 15% body weight | BMI 30+ or 27+ with comorbidity | GLP-1 agonist |
| Saxenda liraglutide | 5-7% body weight | Older GLP-1, less effective | GLP-1 agonist |
| NHS Tier 2 programmes | 5-10% body weight | Free local referral via GP | Lifestyle + behaviour |
| Orlistat | 3-5% body weight | NHS or OTC | Fat absorption blocker |
| Bariatric surgery | 25-30% body weight | BMI 40+ or 35+ with conditions | Surgical |
| Jardiance side effect | 2-3kg | Not licensed for weight loss | SGLT2 calorie excretion |
Order-of-magnitude difference. For someone weighing 100kg: Jardiance = 3kg loss. Mounjaro = 20kg loss.
The honest pathway if you have type 2 diabetes + want weight loss
If you have type 2 diabetes and are also carrying excess weight, the conversation with your GP or diabetes specialist is the right starting point.
The NHS pathway — 5-step checklist
- Speak to your GP or diabetes specialist
- If diabetes + heart failure or CKD — Jardiance is appropriate first-line (modest weight loss = bonus)
- If weight loss is primary clinical goal — ask about GLP-1s
- Mounjaro now licensed in UK for BOTH type 2 diabetes AND weight loss
- Combination therapy (Jardiance + GLP-1) needs specialist input
Don’t choose your diabetes medication for the side effect. Choose for primary indication. If you want weight loss, ask for a weight loss drug.
What UK Patients Are Telling Us
“Type 2 diabetes + heart failure. Started Jardiance 2 years ago. Lost 4kg over 6 months as a bonus. HF symptoms massively improved. NHS prescribing was straightforward.”
★★★★★
“Tried to get Jardiance privately for weight loss — clinic happily quoted £80/month. Did some research, found Mounjaro on NHS via Tier 3 service for free. Don’t pay for off-label.”
★★★★★
“Got recurrent thrush on Jardiance for diabetes. Manageable but irritating. Worth it for the diabetes + heart benefit. Wouldn’t take it just for weight loss — risk/benefit doesn’t stack up.”
★★★★☆
“Mounjaro on NHS BMI 32 + type 2 diabetes. 18kg lost in 9 months, HbA1c down from 8.2 to 6.1. Game-changer. Jardiance was nothing in comparison for weight.”
★★★★★
Frequently Asked Questions
Jardiance is for hearts + kidneys, not weight. GLP-1s are for weight loss.
Jardiance does cause a small amount of weight loss as a side effect of its action in the kidneys, but it is not a weight loss medication. Its vital, licensed role in the UK is to protect the hearts and kidneys of people with type 2 diabetes, heart failure, or chronic kidney disease — and the evidence for those uses is genuinely strong.
If you’re seeking meaningful weight management, the evidence-based path lies in speaking to your GP about the proven options: GLP-1 medications like Mounjaro and Wegovy, NHS Tier 2 lifestyle programmes, or bariatric surgery for severe obesity. Pursuing Jardiance off-label for weight loss isn’t supported by evidence, NICE guidelines, or NHS prescribing — and it bypasses the safer, more effective treatments designed for that very purpose.
Related reading: Ashwagandha Weight Loss UK Evidence · PCOS Belly — What It Is & Why It Happens · Signs Perimenopause Is Ending
Published: · Last updated:
Walton Surgery · NHS GP Practice · waltonsurgery.co.uk
